Antitumor activity of constituents of Pseudomonas aeruginosa.
D000818:Animals; D001426:Bacterial Proteins / Q000032:analysis / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004731:Endotoxins / Q000032:analysis / Q000627:therapeutic use*; D005260:Female; D051379:Mice; D011550:Pseudomonas aeruginosa / Q000032:analysis*; D012510:Sarcoma 180 / Q000188:drug therapy*
D001426:Bacterial Proteins; D004731:Endotoxins